Evidence map›Paper›PMID 32565126›Full record

ArticleVirus research2020

Targeting the SARS-CoV-2 spike glycoprotein prefusion conformation: virtual screening and molecular dynamics simulations applied to the identification of potential fusion inhibitors.

Alice Romeo, Federico Iacovelli, Mattia Falconi

Open access · greenAbstract read
In one paragraph

Article in Virus research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
1.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 64 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Fluorine Atoms on CInternational journal of molecular sciences · 2022
    Article
  12. Review
  13. Review
  14. Article
  15. Interaction ofInternational journal of environmental research and public health · 2022
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Chemical physics letters · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Alice RomeoDepartment of Biology, Structural Bioinformatics Group, University of Rome Tor Vergata, Rome, Italy.
Federico IacovelliDepartment of Biology, Structural Bioinformatics Group, University of Rome Tor Vergata, Rome, Italy.
Mattia FalconiDepartment of Biology, Structural Bioinformatics Group, University of Rome Tor Vergata, Rome, Italy. Electronic address: falconi@uniroma2.it.
University of Rome Tor Vergata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to a renewed interest in studying the role of the spike S glycoprotein in regulating coronavirus infections in the natural host. Taking advantage of the cryo-electron microscopy structure of SARS-CoV-2 S trimer in the prefusion conformation, we performed a virtual screening simulation with the aim to identify novel molecules that could be used as fusion inhibitors. The spike glycoprotein structure has been completed using modeling techniques and its inner cavity, needful for the postfusion transition of the trimer, has been scanned for the identification of strongly interacting available drugs. Finally, the stability of the protein-drug top complexes has been tested using classical molecular dynamics simulations. The free energy of interaction of the molecules to the spike protein has been evaluated through the MM/GBSA method and per-residue decomposition analysis. Results have been critically discussed considering previous scientific knowledge concerning the selected compounds and sequence alignments have been carried out to evaluate the spike glycoprotein similarity among the betacoronavirus family members. Finally, a cocktail of drugs that may be used as SARS-CoV-2 fusion inhibitors has been suggested.

Indexed as

AnthracenesAntiviral AgentsBetacoronavirusBinding SitesCoronavirus InfectionsCOVID-19Gene ExpressionHeterocyclic Compounds, 4 or More RingsHigh-Throughput Screening AssaysHumansIndolesIsoindolesMolecular Docking SimulationMolecular Dynamics SimulationPandemicsPerylene27-cyclohexyl-12,13,16,17-tetrahydro-22-methoxy-11,17-dimethyl-10,10-dioxide-2,19-methano-3,7:4,1-dimetheno-1H,11H-14,10,2,9,11,17-benzoxathiatetraazacyclo docosine-8,18(9H,15H)-dioneAnthracenesAntiviral AgentsHeterocyclic Compounds, 4 or More RingshypericinIndolesIsoindolesPerylenephthalocyanineSmall Molecule LibrariesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2SulfonamidesFusion inhibitorsMolecular dynamicsSARS-CoV-2Sequence alignmentSpike glycoproteinVirtual screening

Identifiers

PMID32565126
PMCPMC7301794
OpenAlexW3036854260

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.